Lineage Cell Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,111	403	687	699	1,284	849
Market Cap Growth	140.65%	-41.27%	-1.77%	-45.56%	51.35%	84.30%
Enterprise Value	990	289	544	471	1,087	732
Last Close Price	4.82	1.86	3.91	3.92	7.74	5.59
PS Ratio	31.02	11.66	21.32	13.53	95.13	144.57
PB Ratio	16.13	1.44	3.08	2.77	4.54	2.78
P/TBV Ratio	-	5.23	30.84	12.45	11.89	6.86
P/FCF Ratio	-	-	-	307.85	-	-
P/OCF Ratio	-	-	-	187.79	-	-
EV/Sales Ratio	29.54	8.36	16.88	9.11	80.50	124.70
EV/FCF Ratio	-14.32	-	-	207.31	-	-
Debt / Equity Ratio	0.13	0.03	0.05	0.05	0.03	0.04
Debt / FCF Ratio	-	-	-	6.03	-	-
Asset Turnover	0.12	0.09	0.08	0.10	0.03	0.02
Quick Ratio	4.33	3.47	2.02	3.07	2.32	5.35
Current Ratio	4.50	3.65	2.14	3.16	2.37	5.66
Return on Equity (ROE)	-157.75%	-26.73%	-32.07%	-32.37%	-46.52%	-20.05%
Return on Assets (ROA)	-13.65%	-12.53%	-11.80%	-9.44%	-21.77%	-14.16%
Return on Capital Employed (ROCE)	-25.30%	-21.60%	-25.50%	-21.50%	-38.60%	-26.40%
Earnings Yield	-20.16%	-16.80%	-11.27%	-13.21%	-10.42%	-7.82%
FCF Yield	-6.22%	-21.36%	-15.33%	0.33%	-5.79%	-7.51%
Buyback Yield / Dilution	-25.54%	-15.94%	-1.69%	-3.22%	-9.64%	-3.10%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.